Another study demonstrated that Akt phosphorylation by lipopolysaccharide stimulates resistance to oxaliplatin and doxorubicin in human colorectal cancer cells via increased Bcl-xL expression [45]. This evidence concerns the gene AKT1 and colorectal cancer.